_id
6915f01fbc934aba376b1fad
Ticker
RNA
Name
Avidity Biosciences Inc
Exchange
NASDAQ
Address
10578 Science Center Drive, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.aviditybiosciences.com
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Last Close
72.04
Volume
4654813
Current Price
72.6
Change
-0.03
Last Updated
2026-01-06T10:23:33.933Z
Image
data:image/webp;base64,UklGRloBAABXRUJQVlA4IE4BAAAQCQCdASpAAEAAPtFip06oJaMiKBgLUQAaCWgAyDzLIRDcLbyBvNwL+sLxJHvWA5o7KrFX+mYZzlrqaLZ5CBHwS+TsY911hFQH831SoRk30AAA/vWf9H/GhcppUjbF+u76hhGofT/Yqafl38dZCx03bTXVVIY1gkA7XQ4hcqHtKXLi8/qSeiqOX+zezhlYtNzQVO359hHlydT/VFr2ZwdEfkX/Pse/RiZPm8g5fDaYlpPnNjrK594UJZ4c1HB9xYQx9dzYSPXSAxTGbx97o+mStywe7is4I85WCRQ6ZYwl+pObBVG74gu1j+xWiEmPANhv3yxWVxuTzwfWLl/mbtC4usVhvJJoi93Ziv/quSM6w7OTt3Yg942r94kXXN+0RvKgxPEonsSVWiRw5U+3OaJo9VWhS1CqRmUOrVBsGMiwWK/z8HolNFmuZKvLAAAA
Ipo Date
2013-06-28T00:00:00.000Z
Market Cap
10859200512
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.981
Sentiment Sources
3
Rating
4.6
Target Price
74.6364
Strong Buy
9
Buy
6
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
12475000
Cost Of Revenue
-
Gross Profit
12475000
Operating Expenses
201281000
Operating Income
-188806000
Interest Expense
-
Pretax Income
-174442000
Net Income
-174442000
Eps
-1.2650349903912397
Dividends Per Share
-
Shares Outstanding
150675742
Income Tax Expense
-
EBITDA
-173386000
Operating Margin
-1513.4749498997996
Total Other Income Expense Net
14364000
Cash
350158000
Short Term Investments
1525678000
Receivables
15037000
Inventories
-
Total Current Assets
1966017000
Property Plant Equipment
74352000
Total Assets
2134209000
Payables
9626000
Short Term Debt
3967000
Long Term Debt
-
Total Liabilities
247944000
Equity
1886265000
Bs_currency_symbol
USD
Depreciation
1056000
Change In Working Capital
-516000
Cash From Operations
-156173000
Capital Expenditures
3887000
Cash From Investing
-587926000
Cash From Financing
850366000
Net Change In Cash
106251000
Cf_currency_symbol
USD
PE
-
PB
5.307407495765441
ROE
-9.248011281553758
ROA
-8.173613736986397
FCF
-160060000
Fcf Percent
-12.830460921843688
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
12475000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
12475000
Quarters > 0 > income Statement > operating Expenses
201281000
Quarters > 0 > income Statement > operating Income
-188806000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-174442000
Quarters > 0 > income Statement > net Income
-174442000
Quarters > 0 > income Statement > eps
-1.2650349903912397
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
137895000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-173386000
Quarters > 0 > income Statement > operating Margin
-1513.4749498997996
Quarters > 0 > income Statement > total Other Income Expense Net
14364000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
350158000
Quarters > 0 > balance Sheet > short Term Investments
1525678000
Quarters > 0 > balance Sheet > receivables
15037000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1966017000
Quarters > 0 > balance Sheet > property Plant Equipment
74352000
Quarters > 0 > balance Sheet > total Assets
2134209000
Quarters > 0 > balance Sheet > payables
9626000
Quarters > 0 > balance Sheet > short Term Debt
3967000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
247944000
Quarters > 0 > balance Sheet > equity
1886265000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-174442000
Quarters > 0 > cash Flow > depreciation
1056000
Quarters > 0 > cash Flow > change In Working Capital
-516000
Quarters > 0 > cash Flow > cash From Operations
-156173000
Quarters > 0 > cash Flow > capital Expenditures
3887000
Quarters > 0 > cash Flow > cash From Investing
-587926000
Quarters > 0 > cash Flow > cash From Financing
850366000
Quarters > 0 > cash Flow > net Change In Cash
106251000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.2650349903912397
Quarters > 0 > ratios > PB
5.307407495765441
Quarters > 0 > ratios > ROE
-9.248011281553758
Quarters > 0 > ratios > ROA
-8.173613736986397
Quarters > 0 > ratios > FCF
-160060000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-12.830460921843688
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3847000
Quarters > 1 > income Statement > cost Of Revenue
138125000
Quarters > 1 > income Statement > gross Profit
-134278000
Quarters > 1 > income Statement > operating Expenses
36864000
Quarters > 1 > income Statement > operating Income
-171142000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-157315000
Quarters > 1 > income Statement > net Income
-157315000
Quarters > 1 > income Statement > eps
-1.2136442887781396
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
129622000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-170328000
Quarters > 1 > income Statement > operating Margin
-4448.713283077723
Quarters > 1 > income Statement > total Other Income Expense Net
13827000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
243907000
Quarters > 1 > balance Sheet > short Term Investments
939237000
Quarters > 1 > balance Sheet > receivables
8540000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1250560000
Quarters > 1 > balance Sheet > property Plant Equipment
24762000
Quarters > 1 > balance Sheet > total Assets
1368926000
Quarters > 1 > balance Sheet > payables
3914000
Quarters > 1 > balance Sheet > short Term Debt
3925000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
176262000
Quarters > 1 > balance Sheet > equity
1192664000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-157315000
Quarters > 1 > cash Flow > depreciation
-7818000
Quarters > 1 > cash Flow > change In Working Capital
-58170000
Quarters > 1 > cash Flow > cash From Operations
-199666000
Quarters > 1 > cash Flow > capital Expenditures
3343000
Quarters > 1 > cash Flow > cash From Investing
185485000
Quarters > 1 > cash Flow > cash From Financing
3773000
Quarters > 1 > cash Flow > net Change In Cash
-10293000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.2136442887781396
Quarters > 1 > ratios > PB
7.8903674463218465
Quarters > 1 > ratios > ROE
-13.190219542134246
Quarters > 1 > ratios > ROA
-11.491855659107943
Quarters > 1 > ratios > FCF
-203009000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-52.77073043930336
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1573000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
1573000
Quarters > 2 > income Statement > operating Expenses
133090000
Quarters > 2 > income Statement > operating Income
-131517000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-115773000
Quarters > 2 > income Statement > net Income
-115773000
Quarters > 2 > income Statement > eps
-0.8958539680574471
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
129232000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-130732000
Quarters > 2 > income Statement > operating Margin
-8360.902733630006
Quarters > 2 > income Statement > total Other Income Expense Net
15744000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
254203000
Quarters > 2 > balance Sheet > short Term Investments
1125674000
Quarters > 2 > balance Sheet > receivables
36582000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1434975000
Quarters > 2 > balance Sheet > property Plant Equipment
20566000
Quarters > 2 > balance Sheet > total Assets
1459075000
Quarters > 2 > balance Sheet > payables
6633000
Quarters > 2 > balance Sheet > short Term Debt
3884000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
130352000
Quarters > 2 > balance Sheet > equity
1328723000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-115773000
Quarters > 2 > cash Flow > depreciation
785000
Quarters > 2 > cash Flow > change In Working Capital
-23244000
Quarters > 2 > cash Flow > cash From Operations
-124829000
Quarters > 2 > cash Flow > capital Expenditures
3753000
Quarters > 2 > cash Flow > cash From Investing
157188000
Quarters > 2 > cash Flow > cash From Financing
1937000
Quarters > 2 > cash Flow > net Change In Cash
34335000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.8958539680574471
Quarters > 2 > ratios > PB
7.061097911302807
Quarters > 2 > ratios > ROE
-8.713102730968005
Quarters > 2 > ratios > ROA
-7.934684646094273
Quarters > 2 > ratios > FCF
-128582000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-81.74316592498411
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2973000
Quarters > 3 > income Statement > cost Of Revenue
738000
Quarters > 3 > income Statement > gross Profit
2973000
Quarters > 3 > income Statement > operating Expenses
123963000
Quarters > 3 > income Statement > operating Income
-120990000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-102257000
Quarters > 3 > income Statement > net Income
-102257000
Quarters > 3 > income Statement > eps
-0.7957928978886667
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
128497000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-120252000
Quarters > 3 > income Statement > operating Margin
-4069.6266397578206
Quarters > 3 > income Statement > total Other Income Expense Net
18733000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
219868000
Quarters > 3 > balance Sheet > short Term Investments
1281629000
Quarters > 3 > balance Sheet > receivables
28222000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1542290000
Quarters > 3 > balance Sheet > property Plant Equipment
18289000
Quarters > 3 > balance Sheet > total Assets
1563895000
Quarters > 3 > balance Sheet > payables
8461000
Quarters > 3 > balance Sheet > short Term Debt
3844000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
138936000
Quarters > 3 > balance Sheet > equity
1424959000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-102257000
Quarters > 3 > cash Flow > depreciation
738000
Quarters > 3 > cash Flow > change In Working Capital
-6163000
Quarters > 3 > cash Flow > cash From Operations
-99871000
Quarters > 3 > cash Flow > capital Expenditures
3916000
Quarters > 3 > cash Flow > cash From Investing
-64172000
Quarters > 3 > cash Flow > cash From Financing
13724000
Quarters > 3 > cash Flow > net Change In Cash
-150319000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.7957928978886667
Quarters > 3 > ratios > PB
6.5467723632750126
Quarters > 3 > ratios > ROE
-7.176136295851319
Quarters > 3 > ratios > ROA
-6.538610328698538
Quarters > 3 > ratios > FCF
-103787000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-34.90985536495123
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10897000
Annuals > 0 > income Statement > cost Of Revenue
2776000
Annuals > 0 > income Statement > gross Profit
10897000
Annuals > 0 > income Statement > operating Expenses
389833000
Annuals > 0 > income Statement > operating Income
-378936000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-322302000
Annuals > 0 > income Statement > net Income
-322302000
Annuals > 0 > income Statement > eps
-2.888476636016562
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
111582000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-376160000
Annuals > 0 > income Statement > operating Margin
-3477.4341561897772
Annuals > 0 > income Statement > total Other Income Expense Net
56634000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
219868000
Annuals > 0 > balance Sheet > short Term Investments
1281629000
Annuals > 0 > balance Sheet > receivables
28222000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1542290000
Annuals > 0 > balance Sheet > property Plant Equipment
18289000
Annuals > 0 > balance Sheet > total Assets
1563895000
Annuals > 0 > balance Sheet > payables
8461000
Annuals > 0 > balance Sheet > short Term Debt
3844000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
138936000
Annuals > 0 > balance Sheet > equity
1424959000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-322302000
Annuals > 0 > cash Flow > depreciation
2776000
Annuals > 0 > cash Flow > change In Working Capital
-14557000
Annuals > 0 > cash Flow > cash From Operations
-300870000
Annuals > 0 > cash Flow > capital Expenditures
7066000
Annuals > 0 > cash Flow > cash From Investing
-854201000
Annuals > 0 > cash Flow > cash From Financing
1192357000
Annuals > 0 > cash Flow > net Change In Cash
37286000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.888476636016562
Annuals > 0 > ratios > PB
5.643470963024199
Annuals > 0 > ratios > ROE
-22.618334983673215
Annuals > 0 > ratios > ROA
-20.608928348770217
Annuals > 0 > ratios > FCF
-307936000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-28.25878682206112
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
9560000
Annuals > 1 > income Statement > cost Of Revenue
2101000
Annuals > 1 > income Statement > gross Profit
7459000
Annuals > 1 > income Statement > operating Expenses
243057000
Annuals > 1 > income Statement > operating Income
-235598000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-212220000
Annuals > 1 > income Statement > net Income
-212220000
Annuals > 1 > income Statement > eps
-2.9066454829343122
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
73012000
Annuals > 1 > income Statement > income Tax Expense
1933105
Annuals > 1 > income Statement > EBITDA
-233497000
Annuals > 1 > income Statement > operating Margin
-2464.414225941423
Annuals > 1 > income Statement > total Other Income Expense Net
23378000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
185082000
Annuals > 1 > balance Sheet > short Term Investments
410269000
Annuals > 1 > balance Sheet > receivables
8623000
Annuals > 1 > balance Sheet > inventories
-7333000
Annuals > 1 > balance Sheet > total Current Assets
611307000
Annuals > 1 > balance Sheet > property Plant Equipment
16652000
Annuals > 1 > balance Sheet > total Assets
628555000
Annuals > 1 > balance Sheet > payables
8809000
Annuals > 1 > balance Sheet > short Term Debt
3639000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
127791000
Annuals > 1 > balance Sheet > equity
500764000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-212220000
Annuals > 1 > cash Flow > depreciation
2101000
Annuals > 1 > cash Flow > change In Working Capital
61129000
Annuals > 1 > cash Flow > cash From Operations
-119064000
Annuals > 1 > cash Flow > capital Expenditures
4228000
Annuals > 1 > cash Flow > cash From Investing
-130070000
Annuals > 1 > cash Flow > cash From Financing
93864000
Annuals > 1 > cash Flow > net Change In Cash
-155270000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.9066454829343122
Annuals > 1 > ratios > PB
10.507893618550852
Annuals > 1 > ratios > ROE
-42.37924451438202
Annuals > 1 > ratios > ROA
-33.763155173373846
Annuals > 1 > ratios > FCF
-123292000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-12.896652719665273
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
9224000
Annuals > 2 > income Statement > cost Of Revenue
1387000
Annuals > 2 > income Statement > gross Profit
9224000
Annuals > 2 > income Statement > operating Expenses
188137000
Annuals > 2 > income Statement > operating Income
-178913000
Annuals > 2 > income Statement > interest Expense
5690000
Annuals > 2 > income Statement > pretax Income
-173995000
Annuals > 2 > income Statement > net Income
-169077000
Annuals > 2 > income Statement > eps
-3.2413826156972507
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
52162000
Annuals > 2 > income Statement > income Tax Expense
-4918000
Annuals > 2 > income Statement > EBITDA
-177526000
Annuals > 2 > income Statement > operating Margin
-1939.64657415438
Annuals > 2 > income Statement > total Other Income Expense Net
4918000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
340396000
Annuals > 2 > balance Sheet > short Term Investments
270331000
Annuals > 2 > balance Sheet > receivables
3875000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
622942000
Annuals > 2 > balance Sheet > property Plant Equipment
15009000
Annuals > 2 > balance Sheet > total Assets
638800000
Annuals > 2 > balance Sheet > payables
4637000
Annuals > 2 > balance Sheet > short Term Debt
3105000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
60725000
Annuals > 2 > balance Sheet > equity
578075000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-173995000
Annuals > 2 > cash Flow > depreciation
1387000
Annuals > 2 > cash Flow > change In Working Capital
9816000
Annuals > 2 > cash Flow > cash From Operations
-136268000
Annuals > 2 > cash Flow > capital Expenditures
2823000
Annuals > 2 > cash Flow > cash From Investing
-189955000
Annuals > 2 > cash Flow > cash From Financing
346171000
Annuals > 2 > cash Flow > net Change In Cash
19948000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.2413826156972507
Annuals > 2 > ratios > PB
6.5031619426545
Annuals > 2 > ratios > ROE
-29.248280932404963
Annuals > 2 > ratios > ROA
-26.467908578584847
Annuals > 2 > ratios > FCF
-139091000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-15.079249783174328
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
9326000
Annuals > 3 > income Statement > cost Of Revenue
639000
Annuals > 3 > income Statement > gross Profit
9326000
Annuals > 3 > income Statement > operating Expenses
127377000
Annuals > 3 > income Statement > operating Income
-118051000
Annuals > 3 > income Statement > interest Expense
639000
Annuals > 3 > income Statement > pretax Income
-118009000
Annuals > 3 > income Statement > net Income
-117370000
Annuals > 3 > income Statement > eps
-2.833108042869557
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
41428000
Annuals > 3 > income Statement > income Tax Expense
-639000
Annuals > 3 > income Statement > EBITDA
-117412000
Annuals > 3 > income Statement > operating Margin
-1265.8267209950675
Annuals > 3 > income Statement > total Other Income Expense Net
42000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
320448000
Annuals > 3 > balance Sheet > short Term Investments
85095000
Annuals > 3 > balance Sheet > receivables
900000
Annuals > 3 > balance Sheet > inventories
-900000
Annuals > 3 > balance Sheet > total Current Assets
411141000
Annuals > 3 > balance Sheet > property Plant Equipment
15589000
Annuals > 3 > balance Sheet > total Assets
427580000
Annuals > 3 > balance Sheet > payables
2806000
Annuals > 3 > balance Sheet > short Term Debt
1769000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
46150000
Annuals > 3 > balance Sheet > equity
381430000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-118009000
Annuals > 3 > cash Flow > depreciation
639000
Annuals > 3 > cash Flow > change In Working Capital
5338000
Annuals > 3 > cash Flow > cash From Operations
-94813000
Annuals > 3 > cash Flow > capital Expenditures
3740000
Annuals > 3 > cash Flow > cash From Investing
-82517000
Annuals > 3 > cash Flow > cash From Financing
176316000
Annuals > 3 > cash Flow > net Change In Cash
-1014000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.833108042869557
Annuals > 3 > ratios > PB
7.827690428125737
Annuals > 3 > ratios > ROE
-30.771045801326586
Annuals > 3 > ratios > ROA
-27.44983394920249
Annuals > 3 > ratios > FCF
-98553000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-10.567553077417971
Annuals > 3 > health Score
27
Valuation > metrics > PE
-1.2650349903912397
Valuation > metrics > PB
5.307407495765441
Valuation > final Score
26.925925042345593
Valuation > verdict
76.9% Overvalued
Profitability > metrics > ROE
-9.248011281553758
Profitability > metrics > ROA
-8.87286325601457
Profitability > metrics > Net Margin
-13.983326653306614
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.13144706602730793
Risk > metrics > Interest Coverage
-178.7935606060606
Risk > final Score
-655
Risk > verdict
High
Liquidity > metrics > Current Ratio
144.63451776649745
Liquidity > metrics > Quick Ratio
144.63451776649745
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
7
Prev Risks > 1
25
Prev Risks > 2
33
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:29:45.704Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.27
Earnings History > 0 > eps Estimate
-1.14
Earnings History > 0 > eps Difference
-0.13
Earnings History > 0 > surprise Percent
-11.4035
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.21
Earnings History > 1 > eps Estimate
-0.9562
Earnings History > 1 > eps Difference
-0.2538
Earnings History > 1 > surprise Percent
-26.5426
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.9
Earnings History > 2 > eps Estimate
-0.8803
Earnings History > 2 > eps Difference
-0.0197
Earnings History > 2 > surprise Percent
-2.2379
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.8
Earnings History > 3 > eps Estimate
-0.7809
Earnings History > 3 > eps Difference
-0.0191
Earnings History > 3 > surprise Percent
-2.4459
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.65
Earnings History > 4 > eps Estimate
-0.71
Earnings History > 4 > eps Difference
0.06
Earnings History > 4 > surprise Percent
8.4507
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.65
Earnings History > 5 > eps Estimate
-0.79
Earnings History > 5 > eps Difference
0.14
Earnings History > 5 > surprise Percent
17.7215
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.79
Earnings History > 6 > eps Estimate
-0.78
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-1.2821
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.79
Earnings History > 7 > eps Estimate
-0.66
Earnings History > 7 > eps Difference
-0.13
Earnings History > 7 > surprise Percent
-19.697
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.71
Earnings History > 8 > eps Estimate
-0.77
Earnings History > 8 > eps Difference
0.06
Earnings History > 8 > surprise Percent
7.7922
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.66
Earnings History > 9 > eps Estimate
-0.8
Earnings History > 9 > eps Difference
0.14
Earnings History > 9 > surprise Percent
17.5
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.74
Earnings History > 10 > eps Estimate
-0.85
Earnings History > 10 > eps Difference
0.11
Earnings History > 10 > surprise Percent
12.9412
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.88
Earnings History > 11 > eps Estimate
-0.89
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
1.1236
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.82
Earnings History > 12 > eps Estimate
-0.93
Earnings History > 12 > eps Difference
0.11
Earnings History > 12 > surprise Percent
11.828
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.92
Earnings History > 13 > eps Estimate
-0.75
Earnings History > 13 > eps Difference
-0.17
Earnings History > 13 > surprise Percent
-22.6667
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.71
Earnings History > 14 > eps Estimate
-0.8
Earnings History > 14 > eps Difference
0.09
Earnings History > 14 > surprise Percent
11.25
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-01
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.82
Earnings History > 15 > eps Estimate
-0.7
Earnings History > 15 > eps Difference
-0.12
Earnings History > 15 > surprise Percent
-17.1429
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.68
Earnings History > 16 > eps Estimate
-0.68
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-09
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.7
Earnings History > 17 > eps Estimate
-0.71
Earnings History > 17 > eps Difference
0.01
Earnings History > 17 > surprise Percent
1.4085
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.64
Earnings History > 18 > eps Estimate
-0.56
Earnings History > 18 > eps Difference
-0.08
Earnings History > 18 > surprise Percent
-14.2857
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-15
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.43
Earnings History > 19 > eps Estimate
-0.34
Earnings History > 19 > eps Difference
-0.09
Earnings History > 19 > surprise Percent
-26.4706
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.31
Earnings History > 20 > eps Estimate
-0.37
Earnings History > 20 > eps Difference
0.06
Earnings History > 20 > surprise Percent
16.2162
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.23
Earnings History > 21 > eps Estimate
-0.24
Earnings History > 21 > eps Difference
-0.99
Earnings History > 21 > surprise Percent
-412.5
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-08
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.56
Earnings History > 22 > eps Estimate
-1.58
Earnings History > 22 > eps Difference
1.02
Earnings History > 22 > surprise Percent
64.557
Earnings History > 23 > period
2014-09-30
Earnings History > 23 > report Date
2014-09-30
Earnings History > 23 > date
2014-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.29
Earnings History > 23 > eps Estimate
-0.23
Earnings History > 23 > eps Difference
-0.06
Earnings History > 23 > surprise Percent
-26.087
Earnings History > 24 > period
2014-06-30
Earnings History > 24 > report Date
2014-06-30
Earnings History > 24 > date
2014-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.22
Earnings History > 24 > eps Estimate
-0.25
Earnings History > 24 > eps Difference
0.03
Earnings History > 24 > surprise Percent
12
Earnings History > 25 > period
2014-03-31
Earnings History > 25 > report Date
2014-03-31
Earnings History > 25 > date
2014-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0.19
Earnings History > 25 > eps Estimate
-0.03
Earnings History > 25 > eps Difference
0.22
Earnings History > 25 > surprise Percent
733.3333
Earnings History > 26 > period
2013-12-31
Earnings History > 26 > report Date
2013-12-31
Earnings History > 26 > date
2013-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.11
Earnings History > 26 > eps Estimate
-0.12
Earnings History > 26 > eps Difference
0.01
Earnings History > 26 > surprise Percent
8.3333
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AThe Technical Signals Behind (RNA) That Institutions Follow Stock Traders Daily
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$74.6364
Analyst Picks
Strong Buy
9
Buy
6
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 121.80% of the total shares of Avidity Biosciences Inc
1.
FMR Inc(12.5809%)
since
2025/06/30
2.
T. Rowe Price Associates, Inc.(8.4014%)
since
2025/06/30
3.
HHG PLC(8.377%)
since
2025/06/30
4.
RTW INVESTMENTS, LLC(7.4766%)
since
2025/06/30
5.
BlackRock Inc(7.2574%)
since
2025/06/30
6.
Wellington Management Company LLP(7.1896%)
since
2025/06/30
7.
Vanguard Group Inc(7.1885%)
since
2025/06/30
8.
RA Capital Management, LLC(5.6478%)
since
2025/06/30
9.
venBio Select Advisor LLC(5.4798%)
since
2025/06/30
10.
Fidelity Growth Compy Commingled Pl S(4.2661%)
since
2025/07/31
11.
State Street Corp(3.2658%)
since
2025/06/30
12.
Fidelity Growth Company Fund(3.1024%)
since
2025/07/31
13.
US Small-Cap Growth II Equity Comp(3.0707%)
since
2025/06/30
14.
Vanguard Total Stock Mkt Idx Inv(2.7772%)
since
2025/07/31
15.
T. Rowe Price New Horizons(2.7485%)
since
2025/07/31
16.
The Toronto-Dominion Bank(2.746%)
since
2025/06/30
17.
Geode Capital Management, LLC(2.2137%)
since
2025/06/30
18.
Vanguard Health Care Inv(2.2029%)
since
2025/06/30
19.
iShares Russell 2000 ETF(2.1461%)
since
2025/08/31
20.
T. Rowe Price Health Sciences(1.7662%)
since
2025/07/31
21.
Bank of America Corp(1.4297%)
since
2025/06/30
22.
Orbimed Advisors, LLC(1.4091%)
since
2025/06/30
23.
Casdin Capital, LLC(1.3797%)
since
2025/06/30
24.
Polar Capital Holdings PLC(1.3761%)
since
2025/06/30
25.
Janus Henderson Global Life Sciences(1.2731%)
since
2025/06/30
26.
Janus Henderson Global Life Sciences D(1.2731%)
since
2025/06/30
27.
SPDR® S&P Biotech ETF(1.2038%)
since
2025/08/31
28.
Adage Capital Partners Gp LLC(1.1869%)
since
2025/06/30
29.
Vanguard Small Cap Index(1.0801%)
since
2025/07/31
30.
Janus Henderson Glb Life Scn I2 USD(1.0514%)
since
2025/07/31
31.
Janus Global Life Science AUSD(1.0508%)
since
2025/06/30
32.
Vanguard Institutional Extnd Mkt Idx Tr(1.0058%)
since
2025/07/31
33.
T. Rowe Price New Horizons Tr-A(0.9887%)
since
2025/06/30
34.
Vanguard Explorer Inv(0.9552%)
since
2025/06/30
35.
Fidelity Growth Company K6(0.9137%)
since
2025/07/31
36.
Fidelity Small Cap Index(0.8927%)
since
2025/06/30
37.
Goldman Sachs Group Inc(0.8904%)
since
2025/06/30
38.
Siren, L.L.C.(0.8633%)
since
2025/06/30
39.
Janus Henderson US SMID Cap Growth MA(0.8617%)
since
2025/06/30
40.
Charles Schwab Investment Management Inc(0.8148%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.27
EPS Estimate
-1.14
EPS Difference
-0.13
Surprise Percent
-11.4035%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.